Immunochemistry Market in Americas 2024-2028

Report
160 Pages
May 2024
Region: Latin America, North America
TechNavio
ID: 5980920

The immunochemistry market in americas is forecasted to grow by USD 3.62 billion during 2023-2028, accelerating at a CAGR of 6.98% during the forecast period. The report on the immunochemistry market in americas provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increasing incidences of neurological disorders, and technological advances in antibody manufacturing.

The immunochemistry market in americas is segmented as below:

By Product

Consumables
Equipment

By Application

Infectious disease
Cardiology
Oncology
Autoimmune disease
Nephrology and others

By Geographical Landscape

Americas

This study identifies the rising new product launches as one of the prime reasons driving the immunochemistry market in americas growth during the next few years. Also, increasing number of clinical trials and emergence of new disease targets will lead to sizable demand in the market.

The report on the immunochemistry market in americas covers the following areas:

Immunochemistry market in americas sizing
Immunochemistry market in americas forecast
Immunochemistry market in americas industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunochemistry market in americas vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., bioMerieux SA, Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Grifols SA, Hologic Inc., Merck and Co. Inc., Mindray Bio medical Electronics Co. Ltd., PerkinElmer Inc., Quanterix Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Tosoh Corp.. Also, the immunochemistry market in americas analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Americas - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Americas: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)

4 Historic Market Size

4.1 Immunochemistry market in Americas 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on immunochemistry market in Americas 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 22: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 25: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 26: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 27: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 28: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 29: Chart on Product - Market share 2023-2028 (%)
Exhibit 30: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 31: Chart on Comparison by Product
Exhibit 32: Data Table on Comparison by Product
6.3 Consumables - Market size and forecast 2023-2028
Exhibit 33: Chart on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 34: Data Table on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Chart on Consumables - Year-over-year growth 2023-2028 (%)
Exhibit 36: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
6.4 Equipment - Market size and forecast 2023-2028
Exhibit 37: Chart on Equipment - Market size and forecast 2023-2028 ($ million)
Exhibit 38: Data Table on Equipment - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Chart on Equipment - Year-over-year growth 2023-2028 (%)
Exhibit 40: Data Table on Equipment - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 41: Market opportunity by Product ($ million)
Exhibit 42: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 43: Chart on Application - Market share 2023-2028 (%)
Exhibit 44: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 45: Chart on Comparison by Application
Exhibit 46: Data Table on Comparison by Application
7.3 Infectious disease - Market size and forecast 2023-2028
Exhibit 47: Chart on Infectious disease - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Chart on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibit 50: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%)
7.4 Cardiology - Market size and forecast 2023-2028
Exhibit 51: Chart on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibit 52: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Chart on Cardiology - Year-over-year growth 2023-2028 (%)
Exhibit 54: Data Table on Cardiology - Year-over-year growth 2023-2028 (%)
7.5 Oncology - Market size and forecast 2023-2028
Exhibit 55: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 56: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 58: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
7.6 Autoimmune disease - Market size and forecast 2023-2028
Exhibit 59: Chart on Autoimmune disease - Market size and forecast 2023-2028 ($ million)
Exhibit 60: Data Table on Autoimmune disease - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Chart on Autoimmune disease - Year-over-year growth 2023-2028 (%)
Exhibit 62: Data Table on Autoimmune disease - Year-over-year growth 2023-2028 (%)
7.7 Nephrology and others - Market size and forecast 2023-2028
Exhibit 63: Chart on Nephrology and others - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on Nephrology and others - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on Nephrology and others - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on Nephrology and others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Application
Exhibit 67: Market opportunity by Application ($ million)
Exhibit 68: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 70: Chart on Market share By Geographical Landscape - 2023-2028 (%)
Exhibit 71: Data Table on Market share By Geographical Landscape - 2023-2028 (%)
9.2 Geographic comparison
Exhibit 72: Chart on Geographic comparison
Exhibit 73: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 74: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 75: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 77: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 South America - Market size and forecast 2023-2028
Exhibit 78: Chart on South America - Market size and forecast 2023-2028 ($ million)
Exhibit 79: Data Table on South America - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibit 81: Data Table on South America - Year-over-year growth 2023-2028 (%)
9.5 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
Exhibit 83: Data Table on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 84: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 85: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 86: Overview on factors of disruption
11.4 Industry risks
Exhibit 87: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 88: Vendors covered
12.2 Market positioning of vendors
Exhibit 89: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 90: Abbott Laboratories - Overview
Exhibit 91: Abbott Laboratories - Business segments
Exhibit 92: Abbott Laboratories - Key news
Exhibit 93: Abbott Laboratories - Key offerings
Exhibit 94: Abbott Laboratories - Segment focus
12.4 Agilent Technologies Inc.
Exhibit 95: Agilent Technologies Inc. - Overview
Exhibit 96: Agilent Technologies Inc. - Business segments
Exhibit 97: Agilent Technologies Inc. - Key news
Exhibit 98: Agilent Technologies Inc. - Key offerings
Exhibit 99: Agilent Technologies Inc. - Segment focus
12.5 Becton Dickinson and Co.
Exhibit 100: Becton Dickinson and Co. - Overview
Exhibit 101: Becton Dickinson and Co. - Business segments
Exhibit 102: Becton Dickinson and Co. - Key offerings
Exhibit 103: Becton Dickinson and Co. - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 104: Bio Rad Laboratories Inc. - Overview
Exhibit 105: Bio Rad Laboratories Inc. - Business segments
Exhibit 106: Bio Rad Laboratories Inc. - Key news
Exhibit 107: Bio Rad Laboratories Inc. - Key offerings
Exhibit 108: Bio Rad Laboratories Inc. - Segment focus
12.7 Bio Techne Corp.
Exhibit 109: Bio Techne Corp. - Overview
Exhibit 110: Bio Techne Corp. - Business segments
Exhibit 111: Bio Techne Corp. - Key offerings
Exhibit 112: Bio Techne Corp. - Segment focus
12.8 Danaher Corp.
Exhibit 113: Danaher Corp. - Overview
Exhibit 114: Danaher Corp. - Business segments
Exhibit 115: Danaher Corp. - Key news
Exhibit 116: Danaher Corp. - Key offerings
Exhibit 117: Danaher Corp. - Segment focus
12.9 DiaSorin SpA
Exhibit 118: DiaSorin SpA - Overview
Exhibit 119: DiaSorin SpA - Business segments
Exhibit 120: DiaSorin SpA - Key offerings
Exhibit 121: DiaSorin SpA - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 122: F. Hoffmann La Roche Ltd. - Overview
Exhibit 123: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 124: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 125: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Fujirebio Holdings Inc.
Exhibit 126: Fujirebio Holdings Inc. - Overview
Exhibit 127: Fujirebio Holdings Inc. - Product / Service
Exhibit 128: Fujirebio Holdings Inc. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 129: Merck and Co. Inc. - Overview
Exhibit 130: Merck and Co. Inc. - Business segments
Exhibit 131: Merck and Co. Inc. - Key news
Exhibit 132: Merck and Co. Inc. - Key offerings
Exhibit 133: Merck and Co. Inc. - Segment focus
12.13 Quanterix Corp.
Exhibit 134: Quanterix Corp. - Overview
Exhibit 135: Quanterix Corp. - Product / Service
Exhibit 136: Quanterix Corp. - Key offerings
12.14 Randox Laboratories Ltd.
Exhibit 137: Randox Laboratories Ltd. - Overview
Exhibit 138: Randox Laboratories Ltd. - Key offerings
12.15 Siemens AG
Exhibit 139: Siemens AG - Overview
Exhibit 140: Siemens AG - Business segments
Exhibit 141: Siemens AG - Key news
Exhibit 142: Siemens AG - Key offerings
Exhibit 143: Siemens AG - Segment focus
12.16 Sysmex Corp.
Exhibit 144: Sysmex Corp. - Overview
Exhibit 145: Sysmex Corp. - Business segments
Exhibit 146: Sysmex Corp. - Key offerings
Exhibit 147: Sysmex Corp. - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 148: Thermo Fisher Scientific Inc. - Overview
Exhibit 149: Thermo Fisher Scientific Inc. - Business segments
Exhibit 150: Thermo Fisher Scientific Inc. - Key news
Exhibit 151: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 152: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 153: Inclusions checklist
Exhibit 154: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 155: Currency conversion rates for US$
13.4 Research methodology
Exhibit 156: Research methodology
Exhibit 157: Validation techniques employed for market sizing
Exhibit 158: Information sources
13.5 List of abbreviations
Exhibit 159: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Americas - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Americas: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Historic Market Size - Data Table on immunochemistry market in Americas 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Five forces analysis - Comparison between 2023 and 2028
Exhibits 23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 25: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 28: Chart on Market condition - Five forces 2023 and 2028
Exhibits 29: Chart on Product - Market share 2023-2028 (%)
Exhibits 30: Data Table on Product - Market share 2023-2028 (%)
Exhibits 31: Chart on Comparison by Product
Exhibits 32: Data Table on Comparison by Product
Exhibits 33: Chart on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibits 34: Data Table on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Chart on Consumables - Year-over-year growth 2023-2028 (%)
Exhibits 36: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
Exhibits 37: Chart on Equipment - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Data Table on Equipment - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Chart on Equipment - Year-over-year growth 2023-2028 (%)
Exhibits 40: Data Table on Equipment - Year-over-year growth 2023-2028 (%)
Exhibits 41: Market opportunity by Product ($ million)
Exhibits 42: Data Table on Market opportunity by Product ($ million)
Exhibits 43: Chart on Application - Market share 2023-2028 (%)
Exhibits 44: Data Table on Application - Market share 2023-2028 (%)
Exhibits 45: Chart on Comparison by Application
Exhibits 46: Data Table on Comparison by Application
Exhibits 47: Chart on Infectious disease - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Chart on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibits 50: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibits 51: Chart on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Chart on Cardiology - Year-over-year growth 2023-2028 (%)
Exhibits 54: Data Table on Cardiology - Year-over-year growth 2023-2028 (%)
Exhibits 55: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits 58: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits 59: Chart on Autoimmune disease - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Data Table on Autoimmune disease - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Chart on Autoimmune disease - Year-over-year growth 2023-2028 (%)
Exhibits 62: Data Table on Autoimmune disease - Year-over-year growth 2023-2028 (%)
Exhibits 63: Chart on Nephrology and others - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Data Table on Nephrology and others - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Chart on Nephrology and others - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on Nephrology and others - Year-over-year growth 2023-2028 (%)
Exhibits 67: Market opportunity by Application ($ million)
Exhibits 68: Data Table on Market opportunity by Application ($ million)
Exhibits 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 70: Chart on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 71: Data Table on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 72: Chart on Geographic comparison
Exhibits 73: Data Table on Geographic comparison
Exhibits 74: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Chart on South America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Data Table on South America - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Data Table on South America - Year-over-year growth 2023-2028 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Data Table on Market opportunity By Geographical Landscape ($ million)
Exhibits 84: Impact of drivers and challenges in 2023 and 2028
Exhibits 85: Overview on Criticality of inputs and Factors of differentiation
Exhibits 86: Overview on factors of disruption
Exhibits 87: Impact of key risks on business
Exhibits 88: Vendors covered
Exhibits 89: Matrix on vendor position and classification
Exhibits 90: Abbott Laboratories - Overview
Exhibits 91: Abbott Laboratories - Business segments
Exhibits 92: Abbott Laboratories - Key news
Exhibits 93: Abbott Laboratories - Key offerings
Exhibits 94: Abbott Laboratories - Segment focus
Exhibits 95: Agilent Technologies Inc. - Overview
Exhibits 96: Agilent Technologies Inc. - Business segments
Exhibits 97: Agilent Technologies Inc. - Key news
Exhibits 98: Agilent Technologies Inc. - Key offerings
Exhibits 99: Agilent Technologies Inc. - Segment focus
Exhibits 100: Becton Dickinson and Co. - Overview
Exhibits 101: Becton Dickinson and Co. - Business segments
Exhibits 102: Becton Dickinson and Co. - Key offerings
Exhibits 103: Becton Dickinson and Co. - Segment focus
Exhibits 104: Bio Rad Laboratories Inc. - Overview
Exhibits 105: Bio Rad Laboratories Inc. - Business segments
Exhibits 106: Bio Rad Laboratories Inc. - Key news
Exhibits 107: Bio Rad Laboratories Inc. - Key offerings
Exhibits 108: Bio Rad Laboratories Inc. - Segment focus
Exhibits 109: Bio Techne Corp. - Overview
Exhibits 110: Bio Techne Corp. - Business segments
Exhibits 111: Bio Techne Corp. - Key offerings
Exhibits 112: Bio Techne Corp. - Segment focus
Exhibits 113: Danaher Corp. - Overview
Exhibits 114: Danaher Corp. - Business segments
Exhibits 115: Danaher Corp. - Key news
Exhibits 116: Danaher Corp. - Key offerings
Exhibits 117: Danaher Corp. - Segment focus
Exhibits 118: DiaSorin SpA - Overview
Exhibits 119: DiaSorin SpA - Business segments
Exhibits 120: DiaSorin SpA - Key offerings
Exhibits 121: DiaSorin SpA - Segment focus
Exhibits 122: F. Hoffmann La Roche Ltd. - Overview
Exhibits 123: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 124: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 125: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 126: Fujirebio Holdings Inc. - Overview
Exhibits 127: Fujirebio Holdings Inc. - Product / Service
Exhibits 128: Fujirebio Holdings Inc. - Key offerings
Exhibits 129: Merck and Co. Inc. - Overview
Exhibits 130: Merck and Co. Inc. - Business segments
Exhibits 131: Merck and Co. Inc. - Key news
Exhibits 132: Merck and Co. Inc. - Key offerings
Exhibits 133: Merck and Co. Inc. - Segment focus
Exhibits 134: Quanterix Corp. - Overview
Exhibits 135: Quanterix Corp. - Product / Service
Exhibits 136: Quanterix Corp. - Key offerings
Exhibits 137: Randox Laboratories Ltd. - Overview
Exhibits 138: Randox Laboratories Ltd. - Key offerings
Exhibits 139: Siemens AG - Overview
Exhibits 140: Siemens AG - Business segments
Exhibits 141: Siemens AG - Key news
Exhibits 142: Siemens AG - Key offerings
Exhibits 143: Siemens AG - Segment focus
Exhibits 144: Sysmex Corp. - Overview
Exhibits 145: Sysmex Corp. - Business segments
Exhibits 146: Sysmex Corp. - Key offerings
Exhibits 147: Sysmex Corp. - Segment focus
Exhibits 148: Thermo Fisher Scientific Inc. - Overview
Exhibits 149: Thermo Fisher Scientific Inc. - Business segments
Exhibits 150: Thermo Fisher Scientific Inc. - Key news
Exhibits 151: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 152: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 153: Inclusions checklist
Exhibits 154: Exclusions checklist
Exhibits 155: Currency conversion rates for US$
Exhibits 156: Research methodology
Exhibits 157: Validation techniques employed for market sizing
Exhibits 158: Information sources
Exhibits 159: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global immunochemistry market in americas: Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., bioMerieux SA, Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Grifols SA, Hologic Inc., Merck and Co. Inc., Mindray Bio medical Electronics Co. Ltd., PerkinElmer Inc., Quanterix Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Tosoh Corp..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising new product launches."

According to the report, one of the major drivers for this market is the growing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Agilent Technologies Inc.
Becton Dickinson and Co.
Bio Rad Laboratories Inc.
Bio Techne Corp.
bioMerieux SA
Danaher Corp.
DiaSorin SpA
Enzo Biochem Inc.
F. Hoffmann La Roche Ltd.
Fujirebio Holdings Inc.
Grifols SA
Hologic Inc.
Merck and Co. Inc.
Mindray Bio medical Electronics Co. Ltd.
PerkinElmer Inc.
Quanterix Corp.
Randox Laboratories Ltd.
Siemens AG
Sysmex Corp.
Thermo Fisher Scientific Inc.
Tosoh Corp.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2469EUR$2,500USD£2,054GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3951EUR$4,000USD£3,287GBP

The immunochemistry market in americas is segmented as below:

By Product

By Application

By Geographical Landscape

The report on the immunochemistry market in americas covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033

Immunochemistry Analyzer Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Systemic Mastocytosis Treatment Market 2024-2028

Allergy Immunotherapies Market 2024-2028

Flow Cytometry in Oncology and Immunology Global Market Report 2024

About the Immunochemistry Market